Agnes_Delfosse_web_large

Agnès Delfosse

Associate
Paris
About

Agnès Delfosse is a dual-qualified from the Paris and California bars and has worked five years in the United States. Ms. Delfosse focuses her practice on mergers and acquisitions, private equity investments, financings and other corporate matters in a broad range of industries, including pharmaceuticals, telecommunications, banking, technology and energy. 

Ms. Delfosse represents both strategic and private equity clients in structuring, negotiating and documenting a wide array of transactions, including public and private mergers, acquisitions, dispositions, carve-outs of business divisions and asset and stock purchases. Her experience covers both French and U.S. jurisdictions.

Areas of FocusCorporatePrivate EquityMergers and AcquisitionsTechnologyLife Sciences
Professional QualificationsAvocate admitted to the Paris BarAttorney-at-law admitted with the State Bar of California

EXPERIENCE

  • Advising Halma, the global group of life-saving technology companies, on the cross-border acquisition of 100% of the shares and voting rights in French-based Lamidey Noury Medical, reinforcing its international footprint between France and England & Wales.
  • Advising Chemonics International, Inc., a global sustainable development firm, on its acquisition of D.M.I, a French international development company. 
  • Advising Stryker in connection with the acquisition of SERF SAS.
  • Advising Pierre Fabre on the sale of the Centre Immunologie Pierre Fabre, located in Saint-Julien-en-Genevois, together with the research and development activities carried out at the site, to Jubilant Group, an international Indian pharmaceutical group seeking to expand its CRO activities in Europe through the acquisition of a pharmaceutical site. 
  • Advising Renault group on the sale of its Irish business in Ireland.
  • Advising Société Générale on its acquisition of Shine, a French fintech and neobank.
  • Advising Sodexo on its sale of its worldwide home care division.
  • Advising a world-renowned health care provider and insurer on its co-investment in the approximately EUR4.7m offering of GenSight Biologics. 
 

Languages
  • French
  • English

AWARDS AND RECOGNITION

Team recognitions

  •  Legal 500 - Private Equity: LBO - Tier 3 – 2025
    “Availability, in-depth expertise, ability to support both SMEs and large international groups.”
  • Legal 500 - Mergers & acquisitions - Tier 4 – 2025
    “Great organisational capabilities combined with a focused professional approach and excellent connections worldwide.”
  • Option Droit & Affaires – Mergers & acquisitions – 5 stars – 2025
  • Option Droit & Affaires – Private Equity – 5 stars - 2025
 
Education
  • University of UCLA, School of Law, LL.M. in business law, 2019
  • University of Paris II Panthéon-Assas, Master’s degree (M2) in Banking and Finance law (Master 2 de droit bancaire et financier), 2015
  • Université of Paris V Descartes, Master’s degree (M2) in Contracts and Secured Transactions (Master 2 de droit des obligations civiles et commerciales), 2014

Prior Experience

  • Before joining DLA Piper, Agnès was a U.S. associate in a top law firm for global M&A in the United States. She also has worked for a U.S. law firm’s Paris office in the Corporate and M&A department. She also has experience working as counsel for the legal department of a privately held finance company based in Los Angeles.
CallvCardLinkedInPrint

Connect

Phone

+33 (0) 1 40 15 24 01
(Work, Paris)